Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 a Multi-center Randomized Blinding Clinical Trial Study

NCT04463420 is registered in ClinicalTrials.gov with Baqiyatallah Medical Sciences University as lead sponsor.

NCT NCT04463420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04463420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 a Multi-center Randomized Blinding Clinical Trial Study
Lead sponsor
Baqiyatallah Medical Sciences University
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2020
Completion date
December 15, 2020
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19